Clinical Trial Update: Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing exemestane to continued tamoxifen in postmenopausal women with early breast cancer; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2014-04-10